Tasmanian Consolidated Regulations Tasmanian Consolidated Regulations
(1) For the purposes of the relevant enactment, a sample of blood taken is to be taken, and each container into which a part of that sample is placed is to be labelled, in a manner that conforms with such of the following requirements as are respectively applicable to the taking and labelling:
(a) the sample is to consist of approximately 15 millilitres of blood;
(b) no alcohol, ether, acetone or any other volatile organic substance is to be used as, or contained in, the skin disinfectant used at the site from which the sample is taken;
(c) the instruments used for the purpose of taking the sample are to be sterilised in a manner that does not leave any residue of a volatile organic substance on those instruments;
(d) after placing a part of the sample in a suitable container, the cap is to be replaced and the container inverted about 30 times to dissolve the substances contained in the container in the blood and thoroughly mix the solution;
(e) the label on each container is to be marked with the name of the person from whom the sample was taken, the date and time at which it was taken and the name of the medical practitioner or qualified nurse by whom it was taken;
(f) the label on the container containing the control sample, in addition to being marked as prescribed by paragraph (e), is to be marked with the word "Control" .
(2) An instrument packed in a form in which it is intended to be supplied for use in medical practice is taken to have been sterilised in accordance with subregulation (1)(c).
(3) In this regulation –
"control sample" means that part of a blood sample that may not, except as a court may otherwise direct, be analysed or otherwise dealt with except on a request under –(a) in the case of a sample taken under and for the Main Act, section 13B(1) of the Main Act; or
(b) in the case of sample taken under and for the Related Act, section 35(3) of the Related Act;
"relevant enactment" means –(a) for a blood sample taken under and for the Main Act, sections 13(4) and (5A) of the Main Act; and
(b) for a blood sample taken under and for the Related Act, sections 32(2) and (5) of the Related Act.